Riskpilot← Back to searchSign inGet full accessOneMed Oy
OYActiveY-tunnus 1558201-5Metsäläntie 20Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1999— employeeswww.onemed.com
Revenue 2025
EUR 64,3M
-1% vs 2024
EBITDA margin
11.8%
-4% vs 2024
Equity ratio
71.3%
Financial strength
Net profit 2025
EUR 7,4M
-37% vs 2024
| Revenue | EUR 64,3M | -1% |
| EBITDA | EUR 7,6M | -4% |
| Net profit | EUR 7,4M | -37% |
| Total assets | EUR 47,8M | +12% |
| Equity | EUR 34,1M | +28% |
| Employees | — | — |
Legal name
OneMed Oy
Y-tunnus number
1558201-5
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. syyskuuta 1999
Share capital
EUR 5 050 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä sekä hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on terveydenhoito- ja laboratorioalan tuotteiden, kemikaalien ja sairaalatarvikkeiden kauppa, laitteiden huolto sekä muu tähän liittyvä toiminta.
Address
Metsäläntie 20
Website
www.onemed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 91 612 | 69 403 | 67 006 | 65 086 | 64 275 |
| Staff expenses | −6 957 | −6 645 | −7 121 | −7 369 | −7 159 |
| EBITDA | 8 286 | 6 752 | 7 730 | 7 939 | 7 605 |
| Depreciation & amort. | −182 | −176 | −259 | −210 | −822 |
| EBIT | 8 104 | 6 576 | 7 472 | 7 729 | 6 783 |
| Net financials | 1 304 | 1 118 | 4 286 | 6 820 | 2 458 |
| Profit before tax | 8 020 | 7 354 | 11 048 | 13 844 | 8 350 |
| Tax | 906 | 1 573 | −0 | 1 991 | 941 |
| Net profit | 7 114 | 5 781 | 8 734 | 11 853 | 7 410 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 76 461 | 95 989 | 0 | 42 621 | 47 835 |
| Equity | 41 435 | 81 116 | 89 850 | 26 703 | 34 113 |
| Long-term debt | 19 447 | 691 | 0 | 10 | 9 |
| Short-term debt | 15 167 | 12 694 | 0 | 11 732 | 8 877 |
| Total debt | 35 026 | 14 873 | 0 | 14 399 | 13 722 |
EBITDA margin
11.8%
This company
15.8%
Market median
-25% vs market
20212025
Equity ratio
71.3%
This company
38.2%
Market median
+87% vs market
20212025
Return on equity
21.7%
This company
18.4%
Market median
+18% vs market
20212025
Net profit margin
11.5%
This company
8.1%
Market median
+42% vs market
20212025
Asset turnover
1.34×
This company
1.12×
Market median
+20% vs market
20212025
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EH Person with significant control | Person with significant control | 2018 |
HM Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (4) | ||
TT Person with significant control | Person with significant control | 2018 – 2019 |
AJ Audit | Audit | 2019 – 2023 |
MO Chief Executive Officer | Chief Executive Officer | 2011 – 2024 |
KP Audit | Audit | 2018 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2024 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2019 – 2022 | |
| Chairperson | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OneMed Group Oy
OneMed Oy Board members of OneMed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tiia Terhikki Räisänen | Person with significant control | 0 companies |
| Eini Hannele Tiihonen | Person with significant control | 0 companies |
| Anders Johan Svennas | Audit | 0 companies |
| Markus Oskari Henriksson | Chief Executive Officer | 0 companies |
| Kari Pekka Ruskola | Audit | 0 companies |
| Hanna-Leena Merikanto | Chief Executive Officer | 0 companies |
| Lars Olof Ragnar Ingman | Board of Directors | 0 companies |
| Lars Peter Nilsson | Chairperson | 0 companies |
| Thomas Philip Moss | Board of Directors | 0 companies |
| Carl Johan Falk | Chairperson | 0 companies |
| Juha Pekka Kallioniemi | Board of Directors | 0 companies |